The involvement of microRNAs in human pathologies is a firmly established fact. Accordingly, the pharmacological modulation of their activity appears to be a very appealing issue in the development of new types of drugs (miRNA therapeutics). One of the most interesting issues is the possible development of miRNA therapeutics for development of anti-cancer molecules. In this respect appealing molecules are based on peptide nucleic acids (PNAs), displaying a pseudo-peptide backbone composed of N-(2-aminoethyl) glycine units and found to be excellent candidates for antisense and antigene therapies. The major limit in the use of PNAs for alteration of gene expression is the low uptake by eukaryotic cells. The aim of this chapter is to describe methods for determining the activity of PNAs designed to oncomiRNA targets, using as model system miR-221 and its target p27(Kipl) mRNA. The effects of PNAs targeting miR-221 are here presented discussing data obtained using as model system the human breast cancer cell line MDA-MB-231, in which miR-221 is up-regulated and p27(Kipl) down-regulated.

Molecular Methods for Validation of the Biological Activity of Peptide Nucleic Acids Targeting MicroRNAsmiRNA Maturation / Eleonora, Brognara; Enrica, Fabbri; Nicoletta, Bianchi; Alessia, Finotti; Corradini, Roberto; Roberto, Gambari. - 1095:(2014), pp. 165-176. [10.1007/978-1-62703-703-7_14]

Molecular Methods for Validation of the Biological Activity of Peptide Nucleic Acids Targeting MicroRNAsmiRNA Maturation

CORRADINI, Roberto;
2014-01-01

Abstract

The involvement of microRNAs in human pathologies is a firmly established fact. Accordingly, the pharmacological modulation of their activity appears to be a very appealing issue in the development of new types of drugs (miRNA therapeutics). One of the most interesting issues is the possible development of miRNA therapeutics for development of anti-cancer molecules. In this respect appealing molecules are based on peptide nucleic acids (PNAs), displaying a pseudo-peptide backbone composed of N-(2-aminoethyl) glycine units and found to be excellent candidates for antisense and antigene therapies. The major limit in the use of PNAs for alteration of gene expression is the low uptake by eukaryotic cells. The aim of this chapter is to describe methods for determining the activity of PNAs designed to oncomiRNA targets, using as model system miR-221 and its target p27(Kipl) mRNA. The effects of PNAs targeting miR-221 are here presented discussing data obtained using as model system the human breast cancer cell line MDA-MB-231, in which miR-221 is up-regulated and p27(Kipl) down-regulated.
2014
9781627037020
Molecular Methods for Validation of the Biological Activity of Peptide Nucleic Acids Targeting MicroRNAsmiRNA Maturation / Eleonora, Brognara; Enrica, Fabbri; Nicoletta, Bianchi; Alessia, Finotti; Corradini, Roberto; Roberto, Gambari. - 1095:(2014), pp. 165-176. [10.1007/978-1-62703-703-7_14]
File in questo prodotto:
File Dimensione Formato  
Micro_RNA_Book_2014_abstract.pdf

non disponibili

Tipologia: Abstract
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 20.85 kB
Formato Adobe PDF
20.85 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Micro_RNA_Book_2014_preprint.pdf

non disponibili

Tipologia: Documento in Pre-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 500.65 kB
Formato Adobe PDF
500.65 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2682883
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 7
social impact